Charles W. Newhall III, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 7,176 shares at $45.01 ($323K) on 2025-08-27, disclosed to the SEC on 2025-08-29.
Scheduled sale ($323k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 3,588 | $161K | 50.0% |
| 2 | $45.01 | 3,588 | $161K | 50.0% |
| Total | $45.01 avg | 7,176 | $323K | 100% |
| Filing → |
| SUPN | SELL | 2025-08-26 | $64K | — | Filing → |
| SUPN | SELL | 2024-11-12 | $388K | — | Filing → |
| SUPN | SELL | 2023-11-20 | $70K | — | Filing → |